314 related articles for article (PubMed ID: 26615790)
21. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
22. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
23. PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.
Arun I; Roy P; Arora N; Bhave SJ; Nair R; Chandy M
Int J Surg Pathol; 2017 Jun; 25(4):333-338. PubMed ID: 28013563
[TBL] [Abstract][Full Text] [Related]
24. Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature.
Kodama K; Hokama M; Kawaguchi K; Tanaka Y; Hongo K
Neuropathology; 2009 Apr; 29(2):166-71. PubMed ID: 18564100
[TBL] [Abstract][Full Text] [Related]
25. [Co-expression of CD99/MIC2 and ALK in anaplastic large-cell lymphoma tissues and its significance].
Zhong L; Wei QZ; Huang XP; Ji TH; Li F; Wang ZQ; Li XZ; Liu JH; Zhao T
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):173-6. PubMed ID: 22781601
[TBL] [Abstract][Full Text] [Related]
26. Primary gastrointestinal anaplastic large cell lymphoma.
Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic Large Cell Lymphoma.
Medeiros LJ; Elenitoba-Johnson KS
Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
[TBL] [Abstract][Full Text] [Related]
28. A Giant Anaplastic Lymphoma Kinase Positive Anaplastic Large Cell Lymphoma: Case Report.
Dai X; Ma J; Ming C; Gao Y; Lou F; Zhang T; He Q
Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702689
[TBL] [Abstract][Full Text] [Related]
29. ALK-negative anaplastic large cell lymphoma with "Hodgkin-like" cytomorphology and nuclear expression of PAX5.
Fratoni S; Niscola P; Zhao XF; Larocca LM; Capalbo A; Fabbretti M; Bernardini L; Abruzzese E
Pathol Res Pract; 2020 Feb; 216(2):152724. PubMed ID: 31784094
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
31. Primary central nervous system ALK-negative anaplastic large cell lymphoma: a case report and literature review.
Yuan C; Duan H; Wang Y; Zhang J; Ou J; Wang W; Zhang M
Ann Palliat Med; 2022 Apr; 11(4):1554-1560. PubMed ID: 34263607
[TBL] [Abstract][Full Text] [Related]
32. PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement.
Ong DM; Cummins KD; Pham A; Grigoriadis G
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26187868
[TBL] [Abstract][Full Text] [Related]
33. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Gru AA; Voorhess PJ
Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
[TBL] [Abstract][Full Text] [Related]
34. Primary central nervous system ALK-positive anaplastic large cell lymphoma in an adult: A rare case report.
Dong X; Li J; Huo N; Wang Y; Wu Z; Lin X; Zhao H
Medicine (Baltimore); 2016 Dec; 95(49):e5534. PubMed ID: 27930548
[TBL] [Abstract][Full Text] [Related]
35. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
36. Small cell variant of ALK-positive anaplastic large cell lymphoma with primary subcutaneous presentation: A case report.
Jaing TH; Chang TY; Chen SH; Wen YC; Chuang WY; Yang CP
Medicine (Baltimore); 2018 Jun; 97(26):e11222. PubMed ID: 29952979
[TBL] [Abstract][Full Text] [Related]
37. The masquerading presentation of a systemic anaplastic large cell lymphoma, ALK positive: a case report and review of the literature.
Al-Ahmad S; Maertens V; Libeer C; Schelfhout V; Vanhoenacker F; Boeckx N; Vandevenne M
Acta Clin Belg; 2017 Dec; 72(6):454-460. PubMed ID: 28441913
[TBL] [Abstract][Full Text] [Related]
38. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
39.
Wang M; Kibbi N; Ring N; Siddon A; Foss F; Totonchy M
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570354
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.
Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC
Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
